GlassScriptPhysician profile
Karl N Becker
NPI 1114471745
$3,085.07
in general payments reported to CMS, 2019-2025
19 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $548 · 2021: $270 · 2022: $575 · 2023: $655 · 2024: $426 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,183 · Entertainment: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,182.75 |
| Entertainment | $129.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,134.20 | 2019-2025 | Clareon, Centurion, Clareon Panoptix Pro |
| Regeneron Healthcare Solutions, INC. | $460.48 | 2019-2025 | Eylea, Eylea Hd |
| Abbvie INC. | $364.29 | 2022-2025 | Xen Glaucoma Treatment System, Ozurdex |
| Eyepoint US, INC. | $186.31 | 2020-2022 | |
| Glaukos Corporation | $148.02 | 2022-2024 | Istent Trabecular Micro-Bypass System Model Is3, Idose |
| Optos, INC. | $129.16 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Genentech USA, INC. | $127.07 | 2023-2025 | Vabysmo |
| Alimera Sciences, INC. | $123.77 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $85.83 | 2020 | |
| Astellas Pharma US INC | $83.57 | 2024-2025 | Izervay |
| Mallinckrodt Hospital Products INC. | $49.79 | 2023 | Acthar |
| Iridex Corporation | $41.06 | 2020 | |
| Rxsight INC | $40.30 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $28.58 | 2022 | |
| Oyster Point Pharma, INC. | $19.34 | 2023 | Tyrvaya |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $17.56 | 2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $16.53 | 2024 | Purified Cortrophin Gel |
| Vantage Technology LLC | $16.04 | 2023 | |
| Biotissue Holdings INC. | $13.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.